Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

Completed

• Conditions: Laparoscopic; Robotic; Anterior Resection for Rectal Cancer

• Registration Number: NCT06396845
• Lead Sponsor: Daorong Wang

Brief Summary

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Primary Completion: 2022-01-01
• Study Completion: 2024-01-03
• Status Verified: 2024-04
• Study First Submitted: 2024-04-29
• Study First Submitted QC: 2024-04-29
• Last Update Submitted: 2024-04-29
• Study First Posted: 2024-05-02
• Last Update Posted: 2024-05-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 505

Inclusion Criteria

The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data.

Exclusion Criteria

patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
postoperative recurrence rate	2018-2024	postoperative recurrence rate

Trial Locations

Locations (1)

Northern Jiangsu People's Hospital; 🇨🇳 Yangzhou, Jiangsu, China